Encinitas, CA, United States of America

Ben Wen

This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Novartis Ag, Irm LLC. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ben Wen. Retrieved from https://idiyas.com/inventor/ben-wen-0yus05cf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 9.4

ph-index = 1


Company Filing History:


Years Active: 2009-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ben Wen

Introduction

Ben Wen is a notable inventor based in Encinitas, California. He has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of three patents to his name, Wen's work is paving the way for advancements in medical treatments.

Latest Patents

Wen's latest patents focus on antibody drug conjugates designed for ablating hematopoietic stem cells. The invention provides a method wherein an antibody or antibody fragment that specifically binds to human cKIT is linked to a drug moiety, optionally through a linker. Furthermore, the invention includes pharmaceutical compositions comprising these antibody drug conjugates, along with methods for making and using such compositions in patients requiring hematopoietic stem cell ablation.

Career Highlights

Throughout his career, Ben Wen has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Irm LLC. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in drug development.

Collaborations

Wen has collaborated with esteemed colleagues such as Michael P. Cooke and Anthony E. Boitano. These partnerships have further enhanced his research and development efforts in the field of biotechnology.

Conclusion

Ben Wen's innovative work in antibody drug conjugates exemplifies the impact of dedicated inventors in the medical field. His contributions are vital for advancing treatment options for patients in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…